The goal of this effort is to create and maintain state-of-the-art guidelines on the diagnosis and management of VWD.
More information on how the current ACA lawsuit could affect the bleeding disorders community.
Investigators looked into whether having hemophilia protected patients against cardiovascular disease.
The update reported on a Phase 1/2 clinical trial for the company’s investigational therapy for the treatment of patients with severe hemophilia B/factor IX (FIX) deficiency.
The new web portal for patients and caregivers is intended to provide timely and accurate information on targeted serious adverse events of interest for HEMLIBRA.
This priority review is specifically for adults and children with hemophilia A without FVIII inhibitors.
The new vial size is 3500 IU (international unit).
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car